蛋白激酶抑制剂 Protein kinase inhibitorsThe present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.赫兰斯 A·I·马特奥岗萨雷斯 A·德普拉多...
PROTEIN KINASE INHIBITORS 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 蛋白激酶抑制剂 翻译结果2复制译文编辑译文朗读译文返回顶部...
1. 蛋白激酶抑制剂 ... 3) 蛋白激酶G; protein kinase G;PKG 4) 蛋白激酶抑制剂; protein kinase inhibitors 5) 组蛋白激酶; histone kinase ... www.chemyq.com|基于25个网页 2. 蛋白质激酶抑制剂 pat365.com|基于5个网页 例句 释义: 全部,蛋白激酶抑制剂,蛋白质激酶抑制剂 更多例句筛选 1. Elective...
Proteinkinaseinhibitors1hydrochloride是一种有效的HIPK2抑制剂,对HIPK1和HIPK2的IC50值分别为136和74nM,对HIPK2的Kd值为9.5nM。 此产品仅用于科学研究,我们不为任何个人用途提供产品和服务 库存:现货 可选规格 包装 5mg 10mg 25mg 50mg 100mg 数量
Table 5. Anti-inflammatory protein kinase inhibitorsa AgentProgressTrial indication(s)Target categoryTarget-encoding genes PLX-3397 Phase II RA, melanoma, BC, PC, AML, glioblastoma, HL CSF-1/PDGF receptor subfamily CSF1R, FLT3, KIT Masitinib Phase III RA, psoriasis, asthma, MS, AD, mastocytos...
5) protein kinase C inhibitor 蛋白激酶C抑制剂 1. Indolylmaleimides, derived from staurosporine, is a specific class of protein kinase C inhibitors. 吲哚马来酰亚胺类化合物是对星型孢菌素进行结构改造而得到的一类新型蛋白激酶C抑制剂。 更多例句>> ...
上海绩祥生物科技有限公司 联系人:朱经理 手机:17651674962 QQ:1514037746 联系电话:13291224959 QQ:1808732405 QQ:2519676925 QQ:710378061 QQ:524064725 在线询单QQ交流电话询单 产品编号品牌纯度规格库存价格 P412118三化99.00%25mg现货面议 P412118三化99.00%5mg现货面议 ...
主页 / 药理学 / Enzymes / Kinases / Akt (Protein Kinase B) / Akt (Protein Kinase B) InhibitorsAkt (Protein Kinase B) InhibitorsCat. No.产品名称/活性 5773 Akti-1/2 Potent and selective dual Akt1 and 2 inhibitor 2151 API-2 Selective inhibitor of Akt/PKB signaling. Antitumor and antiviral...
PROTEIN KINASE INHIBITORS 专利内容由知识产权出版社提供 专利名称:PROTEIN KINASE INHIBITORS 发明人:ERICKSON, Scott,BAMAUNG, Nwe,FIDANZE, Steve,SHEPPARD, George,WANG, Gary,PALAZZO, Fabio,BELL, Randy,MANTEI, Robert,WANG, Jieyi,HUBBARD, Robert,KAWAI, Megumi 申请号:US200604 94 61 申请日:20061228 ...
tyrosine kinase inhibitors (TKIs), target-specific inhibitors of PTKs, have been used in treating malignant tumors and play a significant role in targeted therapy of cancer. Currently, drug resistance is the main reason for limiting TKIs efficacy of cancer. The increasing studies indicated that tumo...